BACKGROUND: Bone mineral density (BMD) and atherosclerotic arterial calcified plaque (CP) demonstrate inverse relationships through unknown mechanisms. Dickkopf-1 (DKK1) is an endogenous inhibitor of bone formation, and serum DKK1 has been associated with impaired osteoblast activation and susceptibility to bone loss. Plasma DKK1, BMD in the spine, and CP in three arterial beds were assessed in African-Americans (AAs) to determine relationships of serum DKK1 with atherosclerotic vascular calcification. METHODS: Plasma DKK1, computed tomography-derived trabecular volumetric BMD (vBMD) in thoracic and lumbar vertebrae, and coronary artery, carotid artery, and aortoiliac CP were measured in 450 unrelated AAs with type 2 diabetes. Generalized linear models were fitted to test for associations between DKK1, vBMD, and CP. RESULTS: Participants were 56% female with mean/SD/median age of 55.4/9.5/55.0 yr, diabetes duration of 10.3/8.2/8.0 yr, plasma DKK1 of 481.6/271.8/417 pg/ml, coronary artery CP mass score of 284/648/13, carotid artery CP mass score of 46/132/0, and aortoiliac CP mass score of 1613/2910/282. Adjusting for age, sex, body mass index, mean arterial blood pressure, smoking, hemoglobin A(1c), and low-density lipoprotein-cholesterol, DKK1 was inversely associated with coronary artery and aortoiliac CP [parameter estimates -0.0011 (P = 0.0137) and -0.0010 (P = 0.0214), respectively], with a trend for carotid artery CP (P = 0.1404). No associations were observed between DKK1 and vBMD in the thoracic or lumbar vertebrae. CONCLUSIONS: Plasma DKK1 levels were inversely associated with coronary artery and aortoiliac CP, but not vBMD, in this cross-sectional study of AAs with type 2 diabetes. DKK1 may play a role in vascular mineral metabolism in this clinical setting.
BACKGROUND: Bone mineral density (BMD) and atherosclerotic arterial calcified plaque (CP) demonstrate inverse relationships through unknown mechanisms. Dickkopf-1 (DKK1) is an endogenous inhibitor of bone formation, and serum DKK1 has been associated with impaired osteoblast activation and susceptibility to bone loss. Plasma DKK1, BMD in the spine, and CP in three arterial beds were assessed in African-Americans (AAs) to determine relationships of serum DKK1 with atherosclerotic vascular calcification. METHODS: Plasma DKK1, computed tomography-derived trabecular volumetric BMD (vBMD) in thoracic and lumbar vertebrae, and coronary artery, carotid artery, and aortoiliac CP were measured in 450 unrelated AAs with type 2 diabetes. Generalized linear models were fitted to test for associations between DKK1, vBMD, and CP. RESULTS:Participants were 56% female with mean/SD/median age of 55.4/9.5/55.0 yr, diabetes duration of 10.3/8.2/8.0 yr, plasma DKK1 of 481.6/271.8/417 pg/ml, coronary artery CP mass score of 284/648/13, carotid artery CP mass score of 46/132/0, and aortoiliac CP mass score of 1613/2910/282. Adjusting for age, sex, body mass index, mean arterial blood pressure, smoking, hemoglobin A(1c), and low-density lipoprotein-cholesterol, DKK1 was inversely associated with coronary artery and aortoiliac CP [parameter estimates -0.0011 (P = 0.0137) and -0.0010 (P = 0.0214), respectively], with a trend for carotid artery CP (P = 0.1404). No associations were observed between DKK1 and vBMD in the thoracic or lumbar vertebrae. CONCLUSIONS: Plasma DKK1 levels were inversely associated with coronary artery and aortoiliac CP, but not vBMD, in this cross-sectional study of AAs with type 2 diabetes. DKK1 may play a role in vascular mineral metabolism in this clinical setting.
Authors: Mercedes R Carnethon; Alain G Bertoni; Steven Shea; Philip Greenland; Hanyu Ni; David R Jacobs; Mohammed Saad; Kiang Liu Journal: Diabetes Care Date: 2005-11 Impact factor: 19.112
Authors: Ji Li; Ildiko Sarosi; Russell C Cattley; James Pretorius; Frank Asuncion; Mario Grisanti; Sean Morony; Stephen Adamu; Zhaopo Geng; Wanrong Qiu; Paul Kostenuik; David L Lacey; W Scott Simonet; Brad Bolon; Xueming Qian; Victoria Shalhoub; Michael S Ominsky; Hua Zhu Ke; Xiaodong Li; William G Richards Journal: Bone Date: 2006-05-26 Impact factor: 4.398
Authors: Pamela A Marcovitz; Hillary H Tran; Barry A Franklin; William W O'Neill; Michael Yerkey; Judith Boura; Michael Kleerekoper; Christine Z Dickinson Journal: Am J Cardiol Date: 2005-08-22 Impact factor: 2.778
Authors: Matthew J Budoff; Khurram Nasir; Songshou Mao; Philip H Tseng; Alex Chau; Sandy T Liu; Ferdinand Flores; Roger S Blumenthal Journal: Atherosclerosis Date: 2005-10-21 Impact factor: 5.162
Authors: B I Freedman; F C Hsu; C D Langefeld; S S Rich; D M Herrington; J J Carr; J Xu; D W Bowden; L E Wagenknecht Journal: Diabetologia Date: 2005-11-01 Impact factor: 10.122
Authors: László B Tankó; Claus Christiansen; David A Cox; Mary Jane Geiger; Michelle A McNabb; Steven R Cummings Journal: J Bone Miner Res Date: 2005-07-18 Impact factor: 6.741
Authors: Thomas C Register; Keith A Hruska; Jasmin Divers; Donald W Bowden; Nicholette D Palmer; J Jeffrey Carr; Lynne E Wagenknecht; R Caresse Hightower; Jianzhao Xu; S Carrie Smith; Dennis J Dietzen; Carl D Langefeld; Barry I Freedman Journal: J Clin Endocrinol Metab Date: 2013-12-20 Impact factor: 5.958
Authors: Antonia Garcia-Martín; Rebeca Reyes-Garcia; Beatriz García-Fontana; Sonia Morales-Santana; Ana Coto-Montes; Manuel Muñoz-Garach; Pedro Rozas-Moreno; Manuel Muñoz-Torres Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240